A detailed history of Westhampton Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Westhampton Capital, LLC holds 5,900 shares of ABT stock, worth $701,805. This represents 0.34% of its overall portfolio holdings.

Number of Shares
5,900
Previous 6,100 3.28%
Holding current value
$701,805
Previous $633,000 6.16%
% of portfolio
0.34%
Previous 0.35%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$100.07 - $118.13 $20,014 - $23,626
-200 Reduced 3.28%
5,900 $672,000
Q2 2024

Jul 19, 2024

BUY
$100.73 - $112.44 $70,511 - $78,708
700 Added 12.96%
6,100 $633,000
Q1 2024

Apr 18, 2024

SELL
$109.52 - $120.96 $76,664 - $84,672
-700 Reduced 11.48%
5,400 $613,000
Q4 2023

Jan 19, 2024

SELL
$90.19 - $110.4 $126,266 - $154,560
-1,400 Reduced 18.67%
6,100 $671,000
Q2 2023

Jul 17, 2023

BUY
$100.78 - $112.29 $20,156 - $22,458
200 Added 2.74%
7,500 $817,000
Q4 2022

Jan 25, 2023

BUY
$95.06 - $111.52 $66,542 - $78,064
700 Added 10.61%
7,300 $0
Q3 2022

Oct 26, 2022

BUY
$96.76 - $112.03 $34,349 - $39,770
355 Added 5.68%
6,600 $639,000
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $17,351 - $20,972
170 Added 2.8%
6,245 $679,000
Q4 2021

Jan 31, 2022

BUY
$115.53 - $141.46 $8,664 - $10,609
75 Added 1.25%
6,075 $855,000
Q4 2020

Feb 03, 2021

SELL
$105.0 - $114.42 $31,500 - $34,326
-300 Reduced 4.76%
6,000 $657,000
Q2 2020

Jul 17, 2020

SELL
$76.57 - $98.0 $22,970 - $29,400
-300 Reduced 4.55%
6,300 $576,000
Q3 2019

Oct 16, 2019

SELL
$81.84 - $88.74 $49,104 - $53,244
-600 Reduced 8.33%
6,600 $552,000
Q2 2019

Aug 06, 2019

BUY
$72.88 - $85.0 $524,736 - $612,000
7,200 New
7,200 $606,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Westhampton Capital, LLC Portfolio

Follow Westhampton Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westhampton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westhampton Capital, LLC with notifications on news.